NCT07013747 - Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Participants With Mild Acne | Biotech Hunter

Enrollment

120

Participants

Timeline

Start Date

July 3, 2025

Primary Completion Date

June 19, 2029

Study Completion Date

June 19, 2029

Conditions

Acne

Interventions

BIOLOGICAL

Acne mRNA vaccine

Pharmaceutical form: suspension for injection Route of administration: intramuscular

OTHER

Placebo

Pharmaceutical form: liquid solution for injection Route of administration: intramuscular

Trial Locations (4)

RECRUITING

Encore Research Group-Jacksonville Center for Clinical Research- Site Number : 8400006, Jacksonville

RECRUITING

Moore Clinical Research - Brandon- Site Number : 8400007, Brandon

RECRUITING

DelRicht Research- Site Number : 8400003, New Orleans

RECRUITING

Encino Research Center- Site Number : 8400008, Encino

All Listed Sponsors

lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY